Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cell Metabolism

• Publication date

  2010-09-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cmet.2010.06.011PMID 20816090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human IL6 enhances leptin action in mice

  2009cited by this paper
• Interleukin-6 Attenuates Insulin-Mediated Increases in Endothelial Cell Signaling but Augments Skeletal Muscle Insulin Action via Differential Effects on Tumor Necrosis Factor-α Expression

  2009cited by this paper
• MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity.

  2009cited by this paper
• CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

  2009cited by this paper
• Faculty Opinions recommendation of Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity.

  2008cited by this paper
• Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice.

  2008influential reference
• A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance

  2008cited by this paper
• Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats.

  2008cited by this paper
• Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis.

  2007cited by this paper
• Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

  2007cited by this paper
• Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice.

  2006cited by this paper
• Central insulin action in energy and glucose homeostasis.

  2006cited by this paper
• Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.

  2006influential reference
• Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase

  2006cited by this paper
• Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.

  2005cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

  2005influential reference
• IKK-beta links inflammation to obesity-induced insulin resistance.

  2005cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

  2005influential reference
• Agouti-related peptide–expressing neurons are mandatory for feeding

  2005cited by this paper
• Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity.

  2004cited by this paper
• The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?

  2004cited by this paper
• Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity.

  2004cited by this paper
• Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms

  2004cited by this paper
• Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

  2004cited by this paper
• Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.

  2003cited by this paper
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

  2003cited by this paper
• Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.

  2003influential reference
• A central role for JNK in obesity and insulin resistance

  2002cited by this paper
• Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

  2002cited by this paper
• Interleukin-6-deficient mice develop mature-onset obesity

  2002cited by this paper
• Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

  2000cited by this paper
• The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 *

  2000cited by this paper
• High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP

  2000cited by this paper
• Hepatocyte‐specific expression of Cre recombinase

  2000cited by this paper
• A new microvolume technique for bioaffinity assays using two-photon excitation

  2000cited by this paper
• IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

  1998cited by this paper
• Differential Regulation of the p80 Tumor Necrosis Factor Receptor in Human Obesity and Insulin Resistance

  1997cited by this paper
• Kupffer cell depletion by liposome‐delivered drugs: Comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid

  1996cited by this paper
• TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1).

  1995cited by this paper
• TNF‐α inhibits glucose‐induced insulin secretion in a pancreatic β‐cell line (INS‐1)

  1995cited by this paper
• Soluble interleukin 6 receptor is biologically active in vivo.

  1995cited by this paper
• Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

  1994cited by this paper
• Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.

  1994cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism

  1990cited by this paper
• Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism.

  1990cited by this paper
• A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat.

  1985cited by this paper
• The preparation of, and studies on, free cell suspensions from mouse pancreatic islets

  1974cited by this paper
• The FASEB Journal express article 10.1096/fj.03-0311fje. Published online September 4, 2003. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise

  year unknowncited by this paper

• Skeletal Muscle as Endocrine Organ.

  2025cites this paper
• Application and Analysis of Random Forest and Support Vector Classification in Risk Prediction of Childhood Obesity and Hyperuricemia

  2025cites this paper
• Blockade of Interleukin-6 Trans-signaling in the Presence of Certain Gut Microbiota Induces Mature-onset Obesity in Mice

  2025cites this paper
• Advances in Adipose Tissue Biology.

  2025cites this paper
• Association between novel inflammatory biomarkers SII, SIRI, and obesity in sedentary adults: NHANES 2007–2020

  2025cites this paper
• To explore the association between the neutrophil percentage to albumin ratio and low bone mineral density/osteoporosis based on NHANES 2011–2018

  2025cites this paper
• Surfactin alleviates insulin resistance by modulating the AMPK/PI3K/Akt signalling pathway and inactivating inflammatory pathways

  2025cites this paper
• Poly(Ethylene Glycol)‐Modified Catalase Blocking Reactive Oxygen Species for the Treatment of Hepatic Ischemia

  2025cites this paper
• Increased levels of systemic iron content in adult-onset interleukin-6 knockout mice

  2025cites this paper
• The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

  2025cites this paper
• Dysfunction of the Murine Liver with Aging and Its Improvement with the Continuous Consumption of Enterococcus faecalis EC-12

  2024cites this paper
• Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment

  2024cites this paper
• Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages.

  2024cites this paper
• IL-6 receptor inhibition is not associated with body weight or composition: Mendelian randomisation study

  2024cites this paper
• Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses

  2024cites this paper
• Possible Immunomodulating Effect Ketoprofen and Ketoprofen Lysine Salt on the Brain

  2024cites this paper
• IL-6 and diabetic kidney disease

  2024cites this paper
• Exerkines and cardiometabolic benefits of exercise: from bench to clinic

  2024cites this paper
• Adipose tissue-derived mediators of systemic inflammation and metabolic control

  2024cites this paper
• Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects.

  2024cites this paper
• The exercise IL-6 enigma in cancer.

  2023cites this paper
• Adipokines in obesity and metabolic-related-diseases.

  2023cites this paper
• Regulatory T cells require IL6 receptor alpha signaling to control skeletal muscle function and regeneration

  2023cites this paper
• Colorable role of interleukin (IL)-6 in obesity hypertension: A hint from a Chinese adult case-control study.

  2023cites this paper
• Interleukin-6 signaling in osteoblasts regulates bone remodeling during exercise.

  2023cites this paper
• Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications

  2023cites this paper
• Signaling pathways and intervention for therapy of type 2 diabetes mellitus

  2023cites this paper
• Clonal haematopoiesis and risk of chronic liver disease

  2023cites this paper
• Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases.

  2023cites this paper
• Physiological role of cytokines in the regulation of mammalian metabolism.

  2023cites this paper
• Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma

  2022cites this paper
• IL-6 Signaling Attenuates TNF-α Production by Plasmacytoid Dendritic Cells in Rheumatoid Arthritis

  2022cites this paper
• MicroRNA global profiling in cystic fibrosis cell lines reveals dysregulated pathways related with inflammation, cancer, growth, glucose and lipid metabolism, and fertility: an exploratory study

  2022cites this paper
• Macrophages, Chronic Inflammation, and Insulin Resistance

  2022cites this paper
• Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b

  2022cites this paper
• FTO knockout in adipose tissue effectively alleviates hepatic steatosis partially via increasing the secretion of adipocyte-derived IL-6.

  2022cites this paper
• Administration of Hookworm Excretory/Secretory Proteins Improves Glucose Tolerance in a Mouse Model of Type 2 Diabetes

  2022cites this paper
• Interleukin 6 receptor is not directly involved in regulation of body weight in diet-induced obesity with and without physical exercise

  2022cites this paper
• Clonal hematopoiesis and risk of chronic liver disease

  2022cites this paper
• Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium

  2022cites this paper
• Deficiency of interleukin-6 receptor ameliorates PM2.5 exposure-induced pulmonary dysfunction and inflammation but not abnormalities in glucose homeostasis

  2022cites this paper
• Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH

  2022cites this paper
• Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice

  2021cites this paper
• Novel drug discovery strategies for the treatment of decompensated cirrhosis

  2021cites this paper
• Sympathetic nerve-adipocyte interactions in response to acute stress

  2021cites this paper
• Hepatoprotective effects of sericin on aging-induced liver damage in mice

  2021cites this paper
• Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells

  2021cites this paper
• A novel QCM immunosensor development based on gold nanoparticles functionalized sulfur-doped graphene quantum dot and h-ZnS-CdS NC for Interleukin-6 detection.

  2021cites this paper
• Tissue Homeostasis and Inflammation.

  2021cites this paper
• Innate-Immunity Genes in Obesity

  2021cites this paper
• IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction

  2021cites this paper
• New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology

  2021cites this paper
• Interleukins in adipose tissue: Keeping the balance.

  2021cites this paper
• Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease

  2021cites this paper
• IL-6 trans-Signaling Impairs Sprouting Angiogenesis by Inhibiting Migration, Proliferation and Tube Formation of Human Endothelial Cells

  2020cites this paper
• Effects of Aerobic Exercise Protocol on Genes Related to Insulin Resistance and Inflammation in the Pancreas of ob/ob Mice with NAFLD

  2020cites this paper
• Muscle derived interleukin-6 increases exercise capacity by signaling in osteoblasts.

  2020cites this paper
• Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease

  2020cites this paper
• A Novel Molecularly Imprinting Biosensor Including Graphene Quantum Dots/Multi-Walled Carbon Nanotubes Composite for Interleukin-6 Detection and Electrochemical Biosensor Validation

  2020cites this paper
• Regulation of adipose tissue inflammation by interleukin 6

  2020cites this paper
• Metabolic inflammation - a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?

  2020cites this paper
• Peripheral sgp130-mediated trans-signaling blockade induces obesity and insulin resistance in mice via PPARα suppression

  2020cites this paper
• CEG_A_242393 223..234

  2020cites this paper
• Nicotine' actions on energy balance: Friend or foe?

  2020cites this paper
• Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

  2020cites this paper
• Origin and Function of Stress-Induced IL-6 in Murine Models.

  2020cites this paper
• Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigue.

  2020cites this paper
• The modulation of mature dendritic cells from patients with type 1 diabetes using human periodontal ligament stem cells. An in-vitro study

  2020cites this paper
• Repeated acute stress modulates hepatic inflammation and markers of macrophage polarisation in the rat.

  2020cites this paper
• Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

  2019cites this paper
• Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.

  2019cites this paper
• Membrane trafficking as an active regulator of constitutively secreted cytokines

  2019cites this paper
• Immunometabolism: Insights from the Drosophila model

  2019cites this paper
• Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication

  2019cites this paper
• The endocrine function of adipose tissues in health and cardiometabolic disease

  2019cites this paper
• Hookworm infection aggravates metabolic disorder in obesity.

  2019cites this paper
• Cardiotrophin‐1 is an anti‐inflammatory cytokine and promotes IL‐4–induced M2 macrophage polarization

  2019cites this paper
• Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction

  2019cites this paper
• The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice

  2019cites this paper
• Hepatic stress associated with pathologies characterized by disturbed glucose production

  2019cites this paper
• Association of Variants in IL6-Related Genes with Lung Cancer Risk in Moroccan Population

  2019cites this paper
• Targeting Interleukin-6 Signaling in Clinic.

  2019cites this paper
• Targeting innate immune mediators in type 1 and type 2 diabetes

  2019cites this paper
• Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells.

  2019cites this paper
• Physiopathologie de l’insulinorésistance

  2019cites this paper
• High-saturated-fat diet-induced obesity causes hepatic interleukin-6 resistance via endoplasmic reticulum stress[S]

  2019cites this paper
• Acute administration of IL-6 improves indices of hepatic glucose and insulin homeostasis in lean and obese mice.

  2019cites this paper
• The role of interleukin-6 in glucose homeostasis and lipid metabolism

  2019cites this paper
• The Role of White Adipose Tissue in the Development of Obesity-associated Insulin Resistance and Endogenous Fat Mass Control

  2018cites this paper
• Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features

  2018cites this paper
• Interleukin-6 and exercise; early evidence of a novel myokine

  2018cites this paper
• Prostaglandin F2α Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity

  2018cites this paper
• Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation

  2018cites this paper
• [Proinflammatory and Immunoregulatory Functions of Interleukin 6 as Identified by Reverse Genetics].

  2018cites this paper
• Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma

  2018cites this paper
• Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cells

  2018cites this paper
• Regulation of Energy Expenditure and Brown/Beige Thermogenic Activity by Interleukins: New Roles for Old Actors

  2018cites this paper
• Physiological effects of modulating the interleukin-6 axis

  2018cites this paper
• Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease

  2018cites this paper
• Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes

  2018cites this paper